Cargando…
Characterization of DNA damage response deficiency in pancreatic cancer patients from China
Autores principales: | Zhang, Xiaofei, Mao, Tiebo, Zhang, Bei, Xu, Haiyan, Cui, Jiujie, Jiao, Feng, Chen, Dongqin, Wang, Yu, Hu, Jiong, Xia, Qing, Li, Shumin, Yue, Ming, Ma, Jingyu, Yao, Jiayu, Wang, Yongchao, Zhang, Xiao, Chen, Shiqing, Bai, Yuezong, Wang, Yuexiang, Zhang, Xuebin, Liu, Qiang, Sun, Yongwei, Fu, Deliang, Liu, Yingbin, Xiong, Lei, Wang, Liwei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8753133/ https://www.ncbi.nlm.nih.gov/pubmed/34821074 http://dx.doi.org/10.1002/cac2.12238 |
Ejemplares similares
-
Characterization of the genomic landscape in large-scale Chinese patients with pancreatic cancer
por: Zhang, Xiaofei, et al.
Publicado: (2022) -
A narrative review of Safety management of 1 L platinum-based chemotherapy and maintenance olaparib in BRCA mutated advanced pancreatic cancer
por: Yao, Jiayu, et al.
Publicado: (2021) -
Distinguishable Prognostic Signatures and Tumor Immunogenicity Between Pancreatic Head Cancer and Pancreatic Body/Tail Cancer
por: Ge, Weiyu, et al.
Publicado: (2022) -
A novel angiogenesis-based molecular signature related to prognosis and tumor immune interactions of pancreatic cancer
por: Ge, Weiyu, et al.
Publicado: (2022) -
Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response
por: Wang, Yu, et al.
Publicado: (2021)